| Overview |
| bs-7996R |
| CEACAM21 Polyclonal Antibody |
| WB, ELISA, IHC-P, IHC-F, IF(IHC-P), IF(IHC-F), IF(ICC), ICC |
| Human |
| Mouse |
| Specifications |
| Unconjugated |
| Rabbit |
| KLH conjugated synthetic peptide derived from human CEACAM21 |
| 201-293/293 |
| Polyclonal |
| IgG |
| 1ug/ul |
| Purified by Protein A. |
| 0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles. |
| Target |
| 90273 |
| Cell membrane |
| Carcinoembryonic antigen related cell adhesion molecule 21; Carcinoembryonic antigen-related cell adhesion molecule 21; CEA21_HUMAN; CEACAM21; CEACAM3; FLJ13540; MGC119874; OTTHUMP00000199036; R29124_1. |
| Carcinoembryonic antigen (CEA) is one of the most commonly used tumor markers in serum immunoassay determinations of carcinoma. Members of the CEACAM (carcinoembryonic antigen-related cell adhesion molecule) family contain a single N domain, with structural homology to the immunoglobulin variable domains, followed by a variable number of immunoglobulin constant-like A and/or B domains. CEACAM21 (carcinoembryonic antigen-related cell adhesion molecule 21) is a 293 amino acid single-pass type I membrane protein that belongs to the CEACAM family and contains one Ig-like C2-type domain. CEACAM21 exists as three alternatively spliced isoforms that are encoded by a gene which maps to human chromosome 19. |
| Application Dilution |
| WB |
1:300-5000 |
| ELISA |
1:500-1000 |
| IHC-P |
1:200-400 |
| IHC-F |
1:100-500 |
| IF(IHC-P) |
1:50-200 |
| IF(IHC-F) |
1:50-200 |
| IF(ICC) |
1:50-200 |
| ICC |
1:100-500 |
Powered by Bioz